IXINITY® breaks down barriers to affordable hemophilia B treatment.


New IXINITY patients are eligible for 1 month of IXINITY free—up to 20,000 IU.

Consider switching patients to IXINITY and they can get their first month free.* After the first free month, patients covered by commercial insurance may continue to pay nothing out-of-pocket for IXINITY regardless of their income.

Use the IXINITY Free Trial Request Form to start your patients on IXINITY with a FREE trial.

The first shipment of IXINITY will come with Custom Ancillaries in a reusable pouch for convenient and easy organization of all infusion-related items.

*Up to 20,000 IU.

Your patients will receive an IXINITY Starter Kit with their FREE trial

Your patient’s IXperience, on the go, no matter where their next adventure takes them. Includes an information-packed IXINITY brochure.

IXINITY Savings Program.

Patients with commercial or private insurance can receive up to $12,000 a year toward their out-of-pocket cost for IXINITY, with no income requirements and no additional monthly limits.

Patients are eligible if they have commercial health insurance. Other restrictions may apply, and a US prescriber and pharmacy are required.

  • This program does not cover costs if patients are on government healthcare coverage, such as Medicare, Medicaid, and TRICARE.
  • This program does not cover costs associated with administration of therapy, such as office visits, infusion costs, or other professional services.

Medexus Pharma reserves the right to rescind, revoke, or amend this offer without notice.

Get your patients started by calling your IXperience Concierge™ at 1-8​55-IXI​NITY (1-8​55-49​4-648​9).

*May depend on individual health insurance.

IXINITY Patient Assistance Program.

This program helps deliver treatment to those in need.

If your patients are uninsured or experience a lapse in their coverage, this program may provide treatment at reduced or no cost.

Find out if your patients are eligible by calling the IXperience Concierge at 1​-8​55​-IXI​NITY (1​-8​55​-4​94​-64​89).

Explore more about IXINITY

Reference: 1. IXINITY [coagulation factor IX (recombinant)] prescribing information. Chicago, IL: Aptevo BioTherapeutics LLC; February 2021.